Female sexual dysfunction in urological patients: findings from a major metropolitan area in the USA

Study Type – Symptom prevalence (prospective cohort)
Level of Evidence 1b OBJECTIVE To determine the prevalence of and risk factors for female sexual dysfunction (FSD) in a practice focused mainly on female urology. PATIENTS AND METHODS A modified version of the Female Sexual Function Index (FSFI) w...

Full description

Saved in:
Bibliographic Details
Published in:BJU international 2010-08, Vol.106 (4), p.524-526
Main Authors: Elsamra, Sammy, Nazmy, Michael, Shin, David, Fisch, Harry, Sawczuk, Ihor, Fromer, Debra
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Epidemiologic Methods
Female
female sexual dysfunction
female urology
Humans
Medical sciences
Middle Aged
Nephrology. Urinary tract diseases
Sexual Dysfunction, Physiological - epidemiology
Sexual Dysfunction, Physiological - etiology
Sexual Dysfunctions, Psychological - epidemiology
Sexual Dysfunctions, Psychological - etiology
sexual health
United States - epidemiology
Urologic Diseases - complications
Urologic Diseases - epidemiology
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Study Type – Symptom prevalence (prospective cohort)
Level of Evidence 1b OBJECTIVE To determine the prevalence of and risk factors for female sexual dysfunction (FSD) in a practice focused mainly on female urology. PATIENTS AND METHODS A modified version of the Female Sexual Function Index (FSFI) was used to assess the prevalence of FSD in 587 patients who completed the questionnaire. Logistic regression was used to identify risk factors. RESULTS The prevalence of FSD was 63%; age, menopausal status and usage of selective serotonin reuptake inhibitors were statistically significant risk factors for FSD. CONCLUSIONS FSD is highly prevalent in this population of patients and screening female urological patients for FSD should be considered.
ISSN:1464-4096
1464-410X
DOI:10.1111/j.1464-410X.2009.09091.x